ChloraPrep

PreclinicalSmall molecule

ZZurex Pharma, Inc.

ChloraPrep is one of 5 small molecule programs targeting Hip Arthroplasty. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Hip ArthroplastyCompleted

Hip ArthroplastyPreclinical

Completed

Competition

Competitive Landscape

4 competitors in Hip Arthroplasty

#DrugCompanyPhaseTrials

Decadron

AAspen Global Incorporated

Approved

2 2

Precedex

MMcNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

Approved

1 3

Liposomal Bupivacaine Plus Bupivacaine

HHuazhong University of Science and Technology

Phase 3

1 4

ChloraPrep

ZZurex Pharma, Inc.

Preclinical

1 5

Duraprep

SSolventum US LLC

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Preoperative6 trials

In Vivo Preoperative Skin Preparation Persistence Evaluation

Completed·SSolventum US LLC·Phase 2·NCT03155178·69 enrolled

In-vivo Efficacy of Patient Preoperative Prep

Completed·ZZurex Pharma, Inc.·Phase 3·NCT02831998·440 enrolled

In Vivo Efficacy Study of Patient Preoperative Preps

Completed·33M·Phase 3·NCT02203591·738 enrolled

Show 3 more trials

Clinical Evaluation of Patient Preoperative Prep

Completed·ZZurex Pharma, Inc.·Phase 3·NCT02831816·640 enrolled

In-vivo Efficacy Study of Patient Preoperative Preps

Terminated·SSolventum US LLC·Phase 3·NCT01968356·171 enrolled

In-vivo Efficacy of Patient Preoperative Prep, ZuraPrep (ZP)

Completed·ZZurex Pharma, Inc.·Phase 3·NCT03782103·156 enrolled

Effectiveness2 trials

Efficacy Study to Evaluate Antimicrobial Effectiveness of ZuraPrep™ (ZX-ZP-0055)

Completed·ZZurex Pharma, Inc.·Phase 2·NCT02296645·36 enrolled

Efficacy Study to Evaluate Antimicrobial Effectiveness of ZuraPrep™

Terminated·ZZurex Pharma, Inc.·Phase 2·NCT02221232·64 enrolled

Efficacy2 trials

An Evaluation of the Efficacy of HEXI-PREP by Clinell Wipes

Completed·GGama Healthcare Ltd.·Phase 3·NCT03417661·93 enrolled

In-vivo Efficacy Study of Patient Pre-operative Preps

Completed·SSolventum US LLC·Phase 3·NCT01968707·426 enrolled

Fracture1 trial

Pre-operative Alcohol Skin Solutions in Fractured Extremities

Completed·UUniversity of Maryland, Baltimore·Phase 4·NCT03523962·8,485 enrolled

Irritation1 trial

Safety Study to Evaluate the Cumulative Irritation Potential of Topically Applied ZuraPrep™ and ZuraPrep™ Without IPA

Completed·ZZurex Pharma, Inc.·Phase 1·NCT02160574·40 enrolled

4 more indications

Surgical1 trial

Compare Effect of Surgical Antiseptic Preparations on Incise Drape Adhesion to Skin

Completed·SSolventum US LLC·Phase 4·NCT01290978·22 enrolled

Hip Arthroplasty1 trial

Efficacy of Surgical Skin Preparation Solutions in Hip Arthroplasty Surgery

Completed·LLakehead University·N/A·NCT03393819·105 enrolled

PrEP1 trial

Safety Study to Evaluate the Contact Sensitizing Potential of Topically Applied ZuraPrep™ and ZuraPrep™ Without IPA

Completed·ZZurex Pharma, Inc.·Phase 1·NCT02160587·208 enrolled

Extremity1 trial

Study on the Reapplication of Chloraprep After Lower Extremity Surgery and Prior to Dressing Application

Unknown status·SSanford Health·Phase 4·NCT02017145·140 enrolled

Sources

References

[1]
ClinicalTrials.gov — 16 trial records for ChloraPrep. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — ChloraPrep compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for ChloraPrep. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Zurex Pharma, Inc. company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: ZZurex Pharma, Inc.

ChloraPrep

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Preoperative6 trials

Effectiveness2 trials

Efficacy2 trials

Fracture1 trial

Irritation1 trial

Surgical1 trial

Hip Arthroplasty1 trial

PrEP1 trial

Extremity1 trial

References

Drug Info

Quick Facts

Related News